The Crucial Role of Clinical Trials for Triple-Negative Breast Cancer Patients

Triple-negative breast cancer (TNBC) is notably aggressive, impacting younger women and women of color. Clinical trials are vital for discovering new treatments. Experts emphasize the importance of staying informed and participating, as breakthroughs like Keytruda emerge from research. Inclusivity in trials is crucial for effective treatment development.